Loading

InVivo Biosystems

June 05, 2024
Company Presentation
CNS/Neurological
Company Presentation Theater 4
In Vivo Biosystems enables drug discovery and development in neurological, metabolic, and rare monogenic disease indications with our premiere proprietary platform, RapidGen. RapidGen leverages -omic data and multiplexed CRISPR to speed target identification & multimodal therapeutics screening on highly relevant behavioral and molecular endpoints in vivo.
InVivo Biosystems
Company Website: https://invivobiosystems.com/
Lead Product in Development: IVB-269
Number Of Unlicensed Products (For Which You Are Seeking Partners): 2

Company HQ City

Eugene

Company HQ State

Oregon

Company HQ Country

United States

CEO/Top Company Official

Kat McCromick

Development Phase of Primary Product

Pre-Clinical
Speakers
Kat McCormick
CEO
InVivo Biosystems
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS